Company Filing History:
Years Active: 2007
Title: Magali Maillet: Innovator in Aryl Carbamate Derivatives
Introduction
Magali Maillet is a notable inventor based in Suresnes, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on aryl carbamate derivatives. Her research focuses on the preparation and therapeutic use of novel compounds that have potential applications in human and animal health.
Latest Patents
Magali Maillet holds a patent for "Aryl carbamate derivatives, preparation and use thereof." This invention relates to novel compounds derived from aryl carbamates, emphasizing their preparation and therapeutic applications. Specifically, these compounds act as 5-HT serotoninergic receptor ligands, which can be utilized in the treatment of various disorders involving 5-HT receptors. The patent also covers pharmaceutical compositions that include these compounds and outlines treatment methods using them. She has 1 patent to her name.
Career Highlights
Throughout her career, Magali Maillet has worked with esteemed organizations such as Cerep and the Centre National De La Recherche Scientifique. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Magali has collaborated with notable colleagues, including Eric Nicolai and Sophie Curtet. These partnerships have enriched her research endeavors and fostered innovation in her field.
Conclusion
Magali Maillet's work on aryl carbamate derivatives showcases her dedication to advancing pharmaceutical science. Her contributions have the potential to impact therapeutic practices significantly.